Advertisement

More articles from Erratum

You have access
Correction to “Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro CYP Induction Studies Including Impact on Drug Interaction Risk Assessment”
Drug Metabolism and Disposition April 2021, 49 (4) 344; DOI: https://doi.org/10.1124/dmd.120.000055err
You have access
Correction to “Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro”
Drug Metabolism and Disposition March 2021, 49 (3) 287-288; DOI: https://doi.org/10.1124/dmd.117.075358err
You have access
Correction to “Investigating the Role of Altered Systemic Albumin Concentration on the Disposition of Theophylline in Adult and Pediatric Patients with Asthma by Using the Physiologically Based Pharmacokinetic Approach”
Drug Metabolism and Disposition January 2021, 49 (1) 120; DOI: https://doi.org/10.1124/dmd.120.090969err
You have access
Correction to “Characterization of Seasonal Pharmacokinetic Variability in Woodchucks”
Drug Metabolism and Disposition December 2020, 48 (12) 1348-1349; DOI: https://doi.org/10.1124/dmd.120.000140err
You have access
Correction to “Gestational Age–Dependent Abundance of Human Placental Transporters as Determined by Quantitative Targeted Proteomics”
Drug Metabolism and Disposition December 2020, 48 (12) 1347; DOI: https://doi.org/10.1124/dmd.120.000067err
You have access
Correction to “Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators”
Drug Metabolism and Disposition November 2020, 48 (11) 1246; DOI: https://doi.org/10.1124/dmd.119.089680err
You have access
Correction to "Dexamethasone-Induced Liver Enlargement Is Related to PXR/YAP Activation and Lipid Accumulation but Not Hepatocyte Proliferation"
Drug Metabolism and Disposition September 2020, 48 (9) 840; DOI: https://doi.org/10.1124/dmd.120.000226
You have access
Correction to “Individual Differences in Metabolic Clearance of S-Warfarin Efficiently Mediated by Polymorphic Marmoset Cytochrome P450 2C19 in Livers”
Drug Metabolism and Disposition August 2020, 48 (8) 723; DOI: https://doi.org/10.1124/dmd.120.000141
You have access
Correction to “Role of Oatp2b1 in Drug Absorption and Drug-Drug Interactions”
Drug Metabolism and Disposition June 2020, 48 (6) 446; DOI: https://doi.org/10.1124/dmd.119.090316err
You have access
Correction to “Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine”
Drug Metabolism and Disposition May 2020, 48 (5) 407; DOI: https://doi.org/10.1124/dmd.119.089656err

Pages